NASDAQ: BIIBBiogen Inc Stock Ownership - Who owns Biogen?
Insider buying vs selling
Have Biogen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sean Godbout | Chief Accounting Officer | 2026-04-01 | 54 | $183.78 | $9.92kSell |
| Nicole Murphy | Head of Pharm Ops and Tech | 2026-02-12 | 3 | $195.04 | $585.11Buy |
| Priya Singhal | Head of Development | 2026-02-09 | 2,660 | $199.83 | $531.55kSell |
| Sean Godbout | Chief Accounting Officer | 2026-02-06 | 76 | $201.18 | $15.29kSell |
| Sean Godbout | Chief Accounting Officer | 2026-02-06 | 103 | $201.18 | $20.72kSell |
| Sean Godbout | Chief Accounting Officer | 2026-02-06 | 180 | $201.18 | $36.21kSell |
| Ginger Gregory | EVP Human Resources | 2026-02-06 | 791 | $201.18 | $159.13kSell |
| Ginger Gregory | EVP Human Resources | 2026-02-06 | 666 | $201.18 | $133.99kSell |
| Ginger Gregory | EVP Human Resources | 2026-02-06 | 1,132 | $201.18 | $227.74kSell |
| Jane Grogan | Head of Research | 2026-02-06 | 407 | $201.18 | $81.88kSell |
BIIB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BIIB insiders and whales buy or sell their stock.
BIIB Shareholders
What type of owners hold Biogen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 11.82% | 17,447,092 | $3.39B | Institution |
| Blackrock Inc | 10.03% | 14,811,370 | $2.88B | Institution |
| Primecap Management Co | 10.00% | 14,757,997 | $2.87B | Institution |
| Fmr LLC | 6.38% | 9,425,863 | $1.83B | Institution |
| State Street Corp | 4.85% | 7,159,020 | $1.39B | Institution |
| Geode Capital Management LLC | 2.84% | 4,199,399 | $816.28M | Institution |
| Wellington Management Group LLP | 2.41% | 3,551,269 | $690.30M | Institution |
| Point72 Asset Management LP | 1.91% | 2,813,192 | $546.83M | Institution |
| Norges Bank | 1.79% | 2,638,834 | $512.94M | Institution |
| Morgan Stanley | 1.57% | 2,325,013 | $451.94M | Institution |
BIIB vs General Drug Manufacturer Stocks
Biogen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.